Literature DB >> 14676636

The spectrum of apocrine lesions of the breast.

F P O'Malley1, A L Bane.   

Abstract

Apocrine change is seen in a wide spectrum of breast lesions, ranging from microscopic cysts to invasive carcinoma. This article reviews the range of apocrine lesions and discusses the clinical significance of these lesions. Although apocrine change in many cases does not present any diagnostic difficulty, apocrine proliferations demonstrating cytologic atypia can be particularly challenging. The histologic criteria that have been proposed to foster reproducibility in categorizing such lesions are reviewed. This review attempts to clarify the terminology that has been applied to a range of benign lesions, including sclerosing adenosis and complex sclerosing lesions, containing foci of apocrine change. Malignant apocrine lesions, including both in situ and invasive carcinoma, are also discussed.

Entities:  

Mesh:

Year:  2004        PMID: 14676636     DOI: 10.1097/00125480-200401000-00001

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  11 in total

1.  Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.

Authors:  Neil Fuehrer; Lynn Hartmann; Amy Degnim; Teresa Allers; Robert Vierkant; Marlene Frost; Daniel Visscher
Journal:  Arch Pathol Lab Med       Date:  2012-02       Impact factor: 5.534

Review 2.  [Diagnostics of benign ductal epithelial cell proliferation of the breast in biopsy material].

Authors:  H-P Sinn; C Flechtenmacher; S Aulmann
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

3.  The immunoexpressions and prognostic significance of inhibin alpha and beta human chorionic gonadotrophins (HCG) in breast carcinomas.

Authors:  Eundeok Chang; Eunjung Lee; Se Jeong Oh; Jeong Soo Kim; Changsuk Kang
Journal:  Cancer Res Treat       Date:  2005-08-31       Impact factor: 4.679

4.  Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.

Authors:  Julio E Celis; José M A Moreira; Irina Gromova; Teresa Cabezón; Pavel Gromov; Tao Shen; Vera Timmermans; Fritz Rank
Journal:  Mol Oncol       Date:  2007-03-14       Impact factor: 6.603

5.  Encapsulated apocrine papillary carcinoma of the breast--a tumour of uncertain malignant potential: report of five cases.

Authors:  Melanie Seal; Christine Wilson; Gregory J Naus; Stephen Chia; Terry C Bainbridge; Malcolm M Hayes
Journal:  Virchows Arch       Date:  2009-10-28       Impact factor: 4.064

6.  Expression of C-KIT, CD24, CD44s, and COX2 in benign and non-invasive apocrine lesions of the breast.

Authors:  Trine Tramm; Jee-Yeon Kim; Sebastian Leibl; Farid Moinfar; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2016-06-10       Impact factor: 4.064

Review 7.  Non-operative breast pathology: apocrine lesions.

Authors:  C A Wells; G A El-Ayat
Journal:  J Clin Pathol       Date:  2007-12       Impact factor: 3.411

8.  [Atypical ductal hyperplasia and atypical epithelial proliferation of ductal type].

Authors:  W Böcker; D Hungermann; S Weigel; K Roterberg; T Decker
Journal:  Pathologe       Date:  2009-02       Impact factor: 1.011

9.  Neoadjuvant targeted therapy for apocrine carcinoma of the breast: A case report.

Authors:  Ping Yang; Shu-Jia Peng; Yan-Ming Dong; Lin Yang; Zhen-Yu Yang; Xi-E Hu; Guo-Qiang Bao
Journal:  World J Clin Cases       Date:  2020-12-06       Impact factor: 1.337

10.  Ductal carcinoma in situ: what the pathologist needs to know and why.

Authors:  Anita Bane
Journal:  Int J Breast Cancer       Date:  2013-02-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.